ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it has entered into securities purchase ...

MilliporeSigma and Simtra BioPharma Solutions have forged a partnership, creating a “turnkey offering” for drugmakers seeking ADC manufacturing.

Its novel mechanism will help to address the growing and significant challenge of ADC sequencing, where differentiation from tubulin and topoisomerase I inhibitor payloads will become imperative.

CBS has opted not to proceed with the proposed Equalizer spinoff starring Titus Welliver. The Equalizer remains in renewal contention.

We're getting the first look at Bosch alum Titus Welliver in an upcoming episode of The Equalizer ahead of a potential spinoff.

Equiniti Trust Company, LLC (EQ) today announced the successful acquisition of the corporate compliance division of ACCESS Newswire Inc., formally known as Issuer Direct Corporation. The ...

Equiniti Trust Company, LLC (EQ) today announced the successful acquisition of the corporate compliance division of ACCESS Newswire Inc., formally known as Issuer Direct Corporation. The compliance ...

Explore the latest advancements and innovative technologies in ADC therapeutics, driving new possibilities for targeted drug delivery.

ADC Therapeutics, a commercial-stage leader in antibody drug conjugates, is focused on developing innovative treatments for hematologic malignancies and solid tumors. The company recently ...

ADC Therapeutics has stopped development of lead solid tumor candidate ADCT-601. The biotech axed the AXL-directed antibody-drug conjugate (ADC) after failing to show a favorable benefit-risk ...

Wall Street predict expect ADC Therapeutics will report losses per share of $0.457 Track ADC Therapeutics stock price in real-time ahead here.